See more : Daphne International Holdings Limited (0210.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Corticeira Amorim, S.G.P.S., S.A. (COR.LS) Income Statement Analysis – Financial Results
- Beijing Enterprises Urban Resources Group Limited (3718.HK) Income Statement Analysis – Financial Results
- Lloyd Fonds AG (L1OA.DE) Income Statement Analysis – Financial Results
- Guangzhou Huayan Precision Machinery Co.,Ltd. (301138.SZ) Income Statement Analysis – Financial Results
- Farglory Life Insurance Co., Ltd. (5859.TWO) Income Statement Analysis – Financial Results
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
About Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. produces and sells functional sugar in China and internationally. It offers oligosaccharide products, such as oligofructose powder and liquid, isomalto oligosaccharide powder and liquid, xylo oligosaccharides, and galto oligosaccharides; dietary fiber products, including polydextrose and resistant dextrin; sugar alcohol products comprising crystalline maltitol and maltitol syrup; starch sugar products that include high fructose syrup, maltodextrin, and high maltose powder; special sugar products that consists of mono cake, bakery, and bread syrups; and fermentation products. The company was founded in 2005 and is based in Yucheng, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 868.26M | 721.89M | 653.36M | 499.62M | 421.05M | 355.53M | 310.61M | 335.52M |
| Cost of Revenue | 584.10M | 493.34M | 471.68M | 335.91M | 261.62M | 234.73M | 191.72M | 209.22M |
| Gross Profit | 284.16M | 228.56M | 181.68M | 163.72M | 159.43M | 120.80M | 118.89M | 126.30M |
| Gross Profit Ratio | 32.73% | 31.66% | 27.81% | 32.77% | 37.86% | 33.98% | 38.28% | 37.64% |
| Research & Development | 32.56M | 27.03M | 23.26M | 15.37M | 15.02M | 11.08M | 10.36M | 10.61M |
| General & Administrative | 11.29M | 10.37M | 12.11M | 9.01M | 6.80M | 3.57M | 9.41M | 11.77M |
| Selling & Marketing | 8.69M | 24.45M | 20.31M | 16.76M | 30.20M | 22.18M | 16.53M | 15.61M |
| SG&A | 19.98M | 34.82M | 32.42M | 25.77M | 37.00M | 25.75M | 25.95M | 27.38M |
| Other Expenses | 7.93M | 8.27M | 6.08M | 3.85M | 6.46M | -1.94M | -1.70M | 2.89M |
| Operating Expenses | 60.47M | 70.13M | 61.76M | 44.99M | 58.48M | 42.12M | 37.68M | 42.01M |
| Cost & Expenses | 644.57M | 563.47M | 533.44M | 380.90M | 320.10M | 276.85M | 229.40M | 251.24M |
| Interest Income | 3.97M | 3.87M | 1.70M | 562.33K | 372.26K | 740.09K | 0.00 | 3.31M |
| Interest Expense | 2.43M | 65.98K | 1.04M | 4.21M | 2.37M | 4.50M | 3.83M | 19.09M |
| Depreciation & Amortization | 47.47M | 48.72M | 47.77M | 43.27M | 32.58M | 27.89M | 25.94M | 24.74M |
| EBITDA | 271.42M | 222.01M | 167.73M | 157.73M | 131.18M | 108.16M | 105.74M | 111.54M |
| EBITDA Ratio | 31.26% | 31.23% | 25.68% | 32.02% | 31.86% | 30.87% | 34.69% | 35.21% |
| Operating Income | 223.69M | 176.48M | 120.25M | 110.75M | 98.73M | 77.64M | 75.84M | 73.59M |
| Operating Income Ratio | 25.76% | 24.45% | 18.40% | 22.17% | 23.45% | 21.84% | 24.42% | 21.93% |
| Total Other Income/Expenses | -2.17M | -3.39M | -1.47M | -662.74K | -2.63M | -1.94M | -1.70M | 2.89M |
| Income Before Tax | 221.52M | 173.09M | 118.77M | 110.09M | 96.10M | 75.70M | 74.14M | 76.48M |
| Income Before Tax Ratio | 25.51% | 23.98% | 18.18% | 22.03% | 22.82% | 21.29% | 23.87% | 22.79% |
| Income Tax Expense | 28.52M | 22.29M | 14.29M | 14.54M | 13.31M | 10.40M | 10.41M | 11.68M |
| Net Income | 193.00M | 150.75M | 104.48M | 95.55M | 82.78M | 65.30M | 63.73M | 64.80M |
| Net Income Ratio | 22.23% | 20.88% | 15.99% | 19.12% | 19.66% | 18.37% | 20.52% | 19.31% |
| EPS | 0.78 | 0.61 | 0.42 | 0.38 | 0.33 | 0.69 | 0.34 | 0.41 |
| EPS Diluted | 0.78 | 0.61 | 0.42 | 0.38 | 0.33 | 0.69 | 0.34 | 0.41 |
| Weighted Avg Shares Out | 247.43M | 248.38M | 248.53M | 248.53M | 248.53M | 94.64M | 186.45M | 158.74M |
| Weighted Avg Shares Out (Dil) | 247.43M | 248.38M | 248.53M | 248.53M | 248.53M | 94.64M | 186.45M | 158.76M |
Source: https://incomestatements.info
Category: Stock Reports